The dataset viewer is not available for this split.
The number of columns (15962) exceeds the maximum supported number of columns (1000). This is a current limitation of the datasets viewer. You can reduce the number of columns if you want the viewer to work.
Error code: TooManyColumnsError
Need help to make the dataset viewer work? Make sure to review how to configure the dataset viewer, and open a discussion for direct support.
DrugDis data
Processed inputs for the code at github.com/Boom5426/DrugDis, which accompanies DrugDis: Disentangling general and context-specific effects in drug-response prediction (project page). Download the whole dataset and point the code at it:
from huggingface_hub import snapshot_download
snapshot_download("Boom5426/DrugDis", repo_type="dataset", local_dir="/path/to/DrugDis-data")
export DRUGDIS_DATA=/path/to/DrugDis-data
Files
| file | contents | built by (in the code repository) |
|---|---|---|
droma.sqlite |
the DROMA database of harmonized preclinical drug-response and omics data | DROMA (doi:10.5281/zenodo.18503188) |
annotations/drug_anno_with_struc_info.csv, annotations/drug_anno_nci60_structure.csv |
compound name to SMILES tables, as used to build drug_response.parquet |
provided as used |
master_table.parquet |
one row per DROMA sample: project, model type, tumour type | drugdis/data/build_processed_tables.py |
drug_response.parquet |
one response per (compound name, sample): canonical SMILES, response value, resource | drugdis/data/build_processed_tables.py |
gdsc_sensitivity_data.parquet |
GDSC1 and GDSC2 responses kept apart; rows before 229,420 are GDSC1 | drugdis/data/build_gdsc_sensitivity.py |
omics_mrna_raw/ |
expression per cohort, samples × genes (.parquet, with .h5ad copies) |
drugdis/data/build_processed_tables.py |
omics_baseline/ |
the 15,961 genes shared by CCLE and GDSC, and all cohorts on those genes | drugdis/data/build_processed_tables.py |
omics_baseline_frozen/ |
the CCLE-derived transcriptomic input matrix of the benchmark dataset (1,406 samples × 15,961 genes) and its provenance record | drugdis/data/build_ccle_substrate.py |
Molecule_Embeddings/ |
ECFP4 (radius 2, 2,048 bits) and eleven pretrained molecular representations, as {canonical SMILES: vector} pickles | ECFP4: drugdis/data/encode_ecfp4.py; others: the published models cited in the manuscript |
Gene_Embeddings/ |
measured expression (Baseline) and eleven pretrained transcriptomic embeddings |
the published models cited in the manuscript |
The benchmark dataset of the manuscript (3,141,680 drug–sample pairs, 986 cell lines,
54,180 compounds) is defined from these files by configs/substrate_config.frozen.json
in the code repository, and the prespecified split manifests are in its manifests/.
Notes on construction
- Overlap rule. When the same compound name is measured on the same sample by
more than one response resource,
drug_response.parquetkeeps the measurement of the first resource in a fixed order (CCLE, CTRP1, CTRP2, FIMM, GDSC1, GDSC2, GRAY, HKUPDO, LICOB, NCI60, PDTXBreast, Prism, Tavor, UHNBreast, UMPDO1, UMPDO2, UMPDO3, Xeva, gCSI). - Tavor. DROMA types the 53 Tavor samples as PDC.
master_table.parquetlabels them "Cell Line", and the benchmark dataset excludes the Tavor project, so Tavor enters neither the cell-line benchmark nor the organoid cohorts. - Organotin compounds. Two NCI60 organotin compounds carry a five-valent
[Sn-]in their SMILES. Their fingerprints are stored under the neutralised[Sn]form, which matches no SMILES indrug_response.parquet, so neither compound is in the benchmark dataset. RDKit 2023.09.4 rejects the[Sn-]form, so a rebuild with it lacks their 109 NCI60 rows and their two fingerprints; every other row and fingerprint is reproduced exactly. - The upstream resources are NCI60, PRISM, CTRP1, CTRP2, GDSC1, GDSC2, CCLE, GRAY, gCSI, FIMM and UHNBreast for cell lines, and UMPDO1, UMPDO2, UMPDO3, HKUPDO and LICOB for organoids. The input-data provenance of DROMA is doi:10.5281/zenodo.17498421.
- Downloads last month
- 373